-
1por Li Ren Kong, Richard Weijie Ong, Tuan Zea Tan, Nur Afiqah Binte Mohamed Salleh, Matan Thangavelu, Jane Vin Chan, Lie Yong Judice Koh, Giridharan Periyasamy, Jieying Amelia Lau, Thi Bich Uyen Le, Lingzhi Wang, Miyoung Lee, Srinivasaraghavan Kannan, Chandra S. Verma, Chwee Ming Lim, Wee Joo Chng, David P. Lane, Ashok Venkitaraman, Huynh The Hung, Chit Fang Cheok, Boon Cher Goh“...Codon 158 gain-of-function mutant p53 (158-mutp53) promotes tumourigenesis in lung cancer. Here...”
Publicado 2020
Enlace del recurso
article -
2por Cecilia B Levandowski, Taylor Jones, Margaret Gruca, Sivapriya Ramamoorthy, Robin D Dowell, Dylan J Taatjes“...The naturally occurring Δ40p53 isoform heterotetramerizes with wild-type p53 (WTp53) to regulate...”
Publicado 2021
Enlace del recurso
article -
3
-
4por Jing Zhao, Alan Blayney, Xiaorong Liu, Lauren Gandy, Weihua Jin, Lufeng Yan, Jeung-Hoi Ha, Ashley J. Canning, Michael Connelly, Chao Yang, Xinyue Liu, Yuanyuan Xiao, Michael S. Cosgrove, Sozanne R. Solmaz, Yingkai Zhang, David Ban, Jianhan Chen, Stewart N. Loh, Chunyu Wang“... to show a direct interaction between EGCG and the tumor suppressor p53 and demonstrate that EGCG inhibits...”
Publicado 2021
Enlace del recurso
article -
5por Tamara Isermann, Özge Çiçek Şener, Adrian Stender, Luisa Klemke, Nadine Winkler, Albrecht Neesse, Jinyu Li, Florian Wegwitz, Ute M. Moll, Ramona Schulz-Heddergott“...Most mutant p53 heterozygous tumours undergo loss of the remaining wildtype (WT) p53 allele which...”
Publicado 2021
Enlace del recurso
article -
6por Marcus J. G. W. Ladds, Ingeborg M. M. van Leeuwen, Catherine J. Drummond, Su Chu, Alan R. Healy, Gergana Popova, Andrés Pastor Fernández, Tanzina Mollick, Suhas Darekar, Saikiran K. Sedimbi, Marta Nekulova, Marijke C. C. Sachweh, Johanna Campbell, Maureen Higgins, Chloe Tuck, Mihaela Popa, Mireia Mayoral Safont, Pascal Gelebart, Zinayida Fandalyuk, Alastair M. Thompson, Richard Svensson, Anna-Lena Gustavsson, Lars Johansson, Katarina Färnegårdh, Ulrika Yngve, Aljona Saleh, Martin Haraldsson, Agathe C. A. D’Hollander, Marcela Franco, Yan Zhao, Maria Håkansson, Björn Walse, Karin Larsson, Emma M. Peat, Vicent Pelechano, John Lunec, Borivoj Vojtesek, Mar Carmena, William C. Earnshaw, Anna R. McCarthy, Nicholas J. Westwood, Marie Arsenian-Henriksson, David P. Lane, Ravi Bhatia, Emmet McCormack, Sonia Laín“...Activation of the tumor suppressor p53 is a promising approach in cancer therapy. Here, the authors...”
Publicado 2018
Enlace del recurso
article -
7por Emil Kofod-Olsen, Janni M L Møller, Mariane H Schleimann, Bettina Bundgaard, Rasmus O Bak, Bodil Øster, Jacob G Mikkelsen, Ted Hupp, Per Höllsberg“... suppressor protein p53. In this study, we have analyzed the activity of p53 after stimulation with p53...”
Publicado 2013
Enlace del recurso
article -
8por Elisabeth Silden, Sigrun M Hjelle, Line Wergeland, André Sulen, Vibeke Andresen, Jean-Christophe Bourdon, David R Micklem, Emmet McCormack, Bjørn Tore Gjertsen“...The carboxy-terminal truncated p53 alternative spliced isoforms, p53β and p53γ, are expressed...”
Publicado 2013
Enlace del recurso
article -
9por Marcus J. G. W. Ladds, Ingeborg M. M. van Leeuwen, Catherine J. Drummond, Su Chu, Alan R. Healy, Gergana Popova, Andrés Pastor Fernández, Tanzina Mollick, Suhas Darekar, Saikiran K. Sedimbi, Marta Nekulova, Marijke C. C. Sachweh, Johanna Campbell, Maureen Higgins, Chloe Tuck, Mihaela Popa, Mireia Mayoral Safont, Pascal Gelebart, Zinayida Fandalyuk, Alastair M. Thompson, Richard Svensson, Anna-Lena Gustavsson, Lars Johansson, Katarina Färnegårdh, Ulrika Yngve, Aljona Saleh, Martin Haraldsson, Agathe C. A. D’Hollander, Marcela Franco, Yan Zhao, Maria Håkansson, Björn Walse, Karin Larsson, Emma M. Peat, Vicent Pelechano, John Lunec, Borivoj Vojtesek, Mar Carmena, William C. Earnshaw, Anna R. McCarthy, Nicholas J. Westwood, Marie Arsenian-Henriksson, David P. Lane, Ravi Bhatia, Emmet McCormack, Sonia LaínEnlace del recurso
Publicado 2018
article -
10por Mizuho Nakayama, Chang Pyo Hong, Hiroko Oshima, Eri Sakai, Seong-Jin Kim, Masanobu Oshima“...Both gain-of-function of mutant p53 (GOF) and loss of wild-type p53 (LOH) are independently...”
Publicado 2020
Enlace del recurso
article -
11
-
12“...Inactivation of the tumor suppressor p53 is the predominant pathogenetic event in head and neck...”
Enlace del recurso
article -
13“...Liou et al. report a 4.6 Å resolution structure of the human p53/ RNA polymerase II assembly, using...”
Enlace del recurso
article -
14“...Remarkably, the <i>p53</i> transcription factor, referred to as “the guardian of the genome...”
Enlace del recurso
article -
15
-
16
-
17“...p53 is a pivotal tumour suppressor that is activated by various cellular stress inducers. Here...”
Enlace del recurso
article -
18“...P53 is regarded as the guardian of the genome, however it is known that mice with increased p53...”
Enlace del recurso
article -
19
-
20“... chemotherapy is highly effective in locally advanced breast cancer. A negative expression of biomarker p53...”
Enlace del recurso
article